Table 2 Methodological design choices and assumption parameters in injury burden of disease studies
Author | Year | Single- or multi-country category? | Geographic Location | Type of study | Injury classification | Classification of injury diagnosis | Design choices of YLL calculations | Design choices of YLD calculations | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
Independent study | GBD-linked study | Cause-of-injury category | Nature-of-injury category | Incidence- or prevalence-based approach? | Usage of disability weights | ||||||
Aldridge et al. [50] | 2017 | Multi-country | WHO European Region | • | • | ICD-9; ICD-10 | WHO standard model life tables | Prevalence | GBD DWs | ||
Begg & Tomijima [60] | 2006 | Multi-country | Global | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs | ||
Crowe et al. [52] | 2020 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | NA | Prevalence | GBD DWs | |
Dhondt et al. [23] | 2012 | Single-country | Belgium (Flanders; Brussels) | • | • | • | ICD-9 (aggregated to the EUROCOST classification) | Belgian life table | Incidence | Empirical DWs; GBD DWs | |
Dhondt et al. [22] | 2013 | Single-country | Belgium (Flanders; Brussels) | • | • | • | ICD-9; ICD-10 (aggregated to the EUROCOST classification) | Belgian LE | Incidence | Dutch DWs; GBD DWs | |
Fattahov & Piankova [64] | 2018 | Single-country | Russia | • | • | ICD-10 | GBD standard model life tables | NA | NA | ||
Franklin et al. [65] | 2020 | Multi-country | Global | • | ICD-9; ICD-10 | GBD standard model life tables | NA | NA | |||
Gobbino et al. (on behalf of CRMSS) [24] | 2012 | Single-country | Italy (Friuli Venezia Giulia) | • | • | • | ICD-9 | Italian life table | Incidence | Australian DWs | |
Haagsma et al. [25] | 2008 | Single-country | Netherlands | • | • | ICD-9 (aggregated to the EUROCOST classification) | NA | Incidence | Empirical DWs | ||
Haagsma et al. [43] | 2012 | Multi-country | Netherlands; Ceres; Thailand | • | • | ICD-10 (aggregated to the EUROCOST classification) | Standard West 26 | Incidence | Empirical DWs | ||
Haagsma et al. [1] | 2016 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | |
Haagsma et al. [54] | 2020 | Multi-country | GBD Western Europe | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | ||
Haagsma et al. [53] | 2020 | Multi-country | Global | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | ||
Hagen et al. [26] | 2020 | Single-country | Norway | • | • | NR | GBD standard model life tables | Incidence | GBD DWs | ||
Hoeymans & Schoemaker [38] | 2010 | Single-country | Netherlands | • | • | • | ICD-10 | Dutch life table | Incidence | Empirical DWs | |
Holtslag et al. [27] | 2008 | Single-country | Netherlands | • | • | NR | Dutch life table | Incidence | Empirical DWs | ||
James et al. [55] | 2019 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | |
James et al. [11] | 2019 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | NA | Prevalence | GBD DWs | |
James et al. [56] | 2020 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | NA | Prevalence | GBD DWs | |
Johnell & Kanis [44] | 2004 | Multi-country | World Bank Regions | • | • | NR | NR | Incidence | GBD DWs | ||
Khan et al. [57] | 2020 | Multi-country | Global | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | ||
Lalloo et al. [58] | 2020 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | |
Lapostolle et al. [28] | 2009 | Single-country | France | • | • | • | ICD-10 (AIS codes) | French LE | Incidence | GBD DWs | |
Leliveld et al. [29] | 2020 | Single-country | Netherlands | • | • | ICD-9; ICD-10 | NA | Incidence | Empirical DWs | ||
Lin [59] | 2016 | Multi-country | Global | • | • | NR | GBD standard model life tables | Prevalence | GBD DWs | ||
Lukaschek et al. [66] | 2012 | Single-country | Germany | • | • | ICD-10 | German LE | NA | NA | ||
Lunevicius & Haagsma [41] | 2018 | Single-country | England (9 English Regions) | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | ||
Lyons et al. [45] | 2017 | Multi-country | EU-28 | • | • | • | ICD-10 | GBD standard model life tables | Incidence | Empirical DWs | |
Majdan et al. [67] | 2017 | Multi-country | EU-16 | • | • | • | ICD-10 | European Union life table | NA | NA | |
Naghavi et al. [68] | 2019 | Multi-country | Global | • | • | ICD-9; ICD-10 | GBD standard model life tables | NA | NA | ||
NHS Health Scotland [39] | 2016 | Single-country | Scotland | • | • | • | ICD-10 | Scottish life table | Prevalence | GBD DWs | |
NHS Health Scotland [40] | 2016 | Single-country | Scotland | • | • | • | ICD-10 | Scottish life table | Prevalence | GBD DWs | |
Peden et al. [61] | 2002 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs | |
Polinder et al. [47] | 2007 | Multi-country | Austria; Denmark; UK (England & Wales); Ireland; Norway; Netherlands | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs | |
Polinder et al. [46] | 2010 | Multi-country | Austria; Latvia; Denmark; UK (England & Wales); Ireland; Netherlands; Norway; Slovenia | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs; Empirical DWs | |
Polinder et al. [31] | 2012 | Single-country | Netherlands | • | • | ICD-9 (aggregated to the EUROCOST classification) | GBD standard model life tables | Incidence | Empirical DWs | ||
Polinder et al. [30] | 2015 | Single-country | Netherlands | • | • | ICD-9 (MAIS code; aggregated to the EUROCOST classification) | GBD standard model life tables | Incidence | Empirical DWs | ||
Prins et al. [32] | 2021 | Single-country | Netherlands | • | • | NA | NA | Incidence | Empirical DWs | ||
Scholten et al. [33] | 2014 | Single-country | Netherlands | • | • | ICD-9 | GBD standard model life tables | Incidence | Empirical DWs | ||
Snijders et al. [34] | 2016 | Single-country | Netherlands | • | • | • | ICD-9 | Dutch life table | Incidence | Empirical DWs | |
Sethi et al. [62] | 2008 | Multi-country | WHO European Region | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs | ||
Spronk et al. [48] | 2020 | Multi-country | Netherlands; New Zealand; Australia | • | • | NA | NA | Incidence | Empirical DWs | ||
Tainio et al. [35] | 2014 | Single-country | Sweden | • | • | • | ICD-9; ICD-10 (AIS code) | GBD standard model life tables | Incidence | GBD DWs | |
Tainio [42] | 2015 | Single-country | Poland | • | • | NR | NR | Polish data on traffic fatalities and GBD 2010 data | NR | ||
Twisk et al. [36] | 2017 | Single-country | Netherlands | • | • | ICD-9 (aggregated to the EUROCOST classification) | Dutch LE | Incidence | Empirical DWs | ||
Valent et al. [63] | 2004 | Multi-country | WHO European Region | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs | ||
Weijermars et al. [37] | 2016 | Single-country | Netherlands | • | • | ICD-9 (aggregated to the EUROCOST classification) | NA | Incidence | Empirical DWs | ||
Weijermarset al. [49] | 2018 | Multi-country | Austria; Spain; Belgium; France; England; Netherlands | • | • | • | ICD-9; ICD-10; aggregated to the EUROCOST classification) | NA | Incidence | Empirical DWs | |